Bajaj Finserv Insurance Subsidiaries Report Nearly ₹18,000 Crore Crore Premium in H1FY26

Bajaj Finserv Limited has released business updates for its unlisted insurance subsidiaries, Bajaj Life Insurance Limited and Bajaj General Insurance Limited, for the month of September 2025 and for the financial year-to-date period up to September 2025.
The figures, submitted to the Insurance Regulatory and Development Authority of India (IRDAI), reflect strong premium growth across life and general insurance segments.
Bajaj General Insurance Posts ₹11,554 Crore in Gross Premium
According to the company’s disclosure on October 11, 2025, Bajaj General Insurance Limited recorded a gross direct premium of ₹2,218.77 crore for September 2025, bringing the cumulative figure for April-September 2025 to ₹11,554.35 crore.
The data has been reported in compliance with the IRDAI Master Circular on Actuarial, Finance and Investment Function of Insurer, 2024 and the IRDAI directive dated October 18, 2024.
Bajaj Life Insurance Records ₹6,327 Crore in New Business Premium
For Bajaj Life Insurance Limited, new business premium for September 2025 stood at ₹1,374.58 crore. The company’s total premium for the period from April 2025 to September 2025 reached ₹6,327.17 crore.
The breakup includes ₹358.85 crore from individual single premiums, ₹3,067.48 crore from individual non-single premiums, ₹2,532.31 crore from group single premiums, and ₹368.53 crore from group yearly renewable premiums. No collections were reported under group non-single premiums for the period.
Read More: Bajaj Finserv Renames Insurance Divisions as Bajaj General Insurance and Bajaj Life Insurance!
Conclusion
Bajaj Finserv’s insurance subsidiaries have demonstrated healthy growth in the first half of FY2026, highlighting steady demand across life and general insurance offerings. With gross premiums exceeding ₹17,800 crore across both segments, the group continues to strengthen its presence in India’s expanding financial services landscape.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Oct 13, 2025, 2:46 PM IST

Team Angel One
- Stocks to Watch Today: Biocon, Laxmi Organic, Innovision and Others (September 9, 2026)
- Top Gainers and Losers on September 7, 2026: Apollo Hospitals and L&T Rise, While Infosys Drops Over 3%
- JLR Plans Job Cuts as UK Government Rules Out Financial Support
- Novartis India Share Price in Focus; Approves ₹1,250 Crore Acquisition of Minipress & Minipres Trademarks
- Auto Retail Sales Rise 18% in August 2026 to Record 2.42 Million Units, Says FADA


